Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply.
Saved in:
| Title: | Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply. |
|---|---|
| Authors: | Syversen SW; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Jahnsen J; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway. |
| Source: | JAMA [JAMA] 2022 Apr 19; Vol. 327 (15), pp. 1506-1507. |
| Publication Type: | Comparative Study; Journal Article; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2022.2938 |
